Accelerated Approval Withdrawals: Will Non-Oncology Indications Stop ‘Dangling’ In 2024?

 
• By Sue Sutter
referee
FDA Commissioner Califf compares FDA accelerated approval decisions to referees 'who don't always make the right call.' • Source: Shutterstock

More from Pink Sheet Perspectives

More from Pink Sheet